Screener
Regeneron Pharmaceuticals REGN Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's net margin?
- Regeneron Pharmaceuticals (REGN) reported net margin of 27.9% in Q2 2026.
- How has Regeneron Pharmaceuticals's net margin changed year-over-year?
- Regeneron Pharmaceuticals's net margin decreased by 11.2% year-over-year, from 31.4% to 27.9%.
- What is the long-term trend for Regeneron Pharmaceuticals's net margin?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's net margin has grown at a -5.3% compound annual growth rate (CAGR), from 41.3% to 31.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Regeneron Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude